Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aysenur Elmali

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 16, 2026
In Regard to Zheng et alAysenur Elmali, Cem Onal
International Journal of Radiation Oncology, Biology, Physics|February 1, 2023
In Regard to Trofimov et alAysenur Elmali, Gozde Yazici
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2024
Letter to the editor concerning 'Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.'Aysenur Elmali, Cem Onal
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 27, 2024
Letter to the editor regarding 'SBRT‑SG‑01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases'Cem Onal, Aysenur Elmali
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2026
Beyond binary response: toward quantitative imaging biomarkers after SBRT in prostate cancerCem Onal, Merve Sezer, Aysenur Elmali
European Urology Oncology|May 20, 2025
Re: Allen Yen, Shanshan Tang, Alana Christie, et al. Predictive Factors for Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Radiation: A Retrospective Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.03.009Cem Onal, Aysenur Elmali, Birhan Demirhan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2024
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas. In regard to Yu et alAysenur Elmali, Erkan Topkan, Cem Onal
European Urology Open Science|November 21, 2025
Re: Daniela E. Oprea-Lagera, Tessa van Elst, Shafak Aluwini, et al. How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. Eur Urol Open Sci 2025; 75: 69-79Birhan Demirhan, Aysenur Elmali, Cem Onal
Cancer|April 7, 2023
Is the hippocampus-sparing attempt really reasonable within the current technological possibilities?Aysenur Elmali, Sepideh Mohammadipour, Gozde Yazici
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 23, 2019
Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study"Melek Tugce Yilmaz, Aysenur Elmali, Gozde Yazici
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|January 16, 2026
In Regard to Zheng et alAysenur Elmali, Cem Onal
International Journal of Radiation Oncology, Biology, Physics|February 1, 2023
In Regard to Trofimov et alAysenur Elmali, Gozde Yazici
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2024
Letter to the editor concerning 'Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.'Aysenur Elmali, Cem Onal
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 27, 2024
Letter to the editor regarding 'SBRT‑SG‑01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases'Cem Onal, Aysenur Elmali
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2026
Beyond binary response: toward quantitative imaging biomarkers after SBRT in prostate cancerCem Onal, Merve Sezer, Aysenur Elmali
European Urology Oncology|May 20, 2025
Re: Allen Yen, Shanshan Tang, Alana Christie, et al. Predictive Factors for Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Radiation: A Retrospective Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.03.009Cem Onal, Aysenur Elmali, Birhan Demirhan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2024
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas. In regard to Yu et alAysenur Elmali, Erkan Topkan, Cem Onal
European Urology Open Science|November 21, 2025
Re: Daniela E. Oprea-Lagera, Tessa van Elst, Shafak Aluwini, et al. How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. Eur Urol Open Sci 2025; 75: 69-79Birhan Demirhan, Aysenur Elmali, Cem Onal
Cancer|April 7, 2023
Is the hippocampus-sparing attempt really reasonable within the current technological possibilities?Aysenur Elmali, Sepideh Mohammadipour, Gozde Yazici
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 23, 2019
Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study"Melek Tugce Yilmaz, Aysenur Elmali, Gozde Yazici
Pageof 6